Novartis AG
Processes and intermediates for NEP inhibitor synthesis
Last updated:
Abstract:
The present invention relates to a new chemical synthesis, intermediates and catalysts useful for the preparation of the neprilysin (NEP) inhibitor sacubitril, inter alia via nitro 5 compounds. It further relates to new intermediate compounds and their use for said new chemical synthesis route, as well as a new catalyst ligand.
Status:
Grant
Type:
Utility
Filling date:
16 Aug 2017
Issue date:
1 Dec 2020